Header cover image

Belgian (BEL20) Biotech Industry Analysis

UpdatedApr 26, 2024
DataAggregated Company Financials
Companies4
  • 7D1.2%
  • 3M-1.8%
  • 1Y0.8%
  • YTD0.3%

Over the last 7 days, the Biotech industry has dropped 5.8%, driven by a pullback from argenx of 5.8%. On the other hand DMS Imaging is actually up 14%. Overall the industry is down 4.5% in 12 months. Earnings are forecast to grow by 56% annually.

Industry Valuation and Performance

Has the Belgian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Apr 2024€20.6b€1.2b-€284,374,406.60n/a-72.5x16.9x
Sun, 24 Mar 2024€22.0b€1.2b-€304,539,046.20n/a-72.2x18.1x
Tue, 20 Feb 2024€21.9b€993.9m-€249,039,866.90n/a-87.9x22x
Thu, 18 Jan 2024€20.5b€1.0b-€288,035,104.00n/a-71.3x19.7x
Sat, 16 Dec 2023€25.2b€1.0b-€287,712,649.00n/a-87.5x24.2x
Mon, 13 Nov 2023€27.0b€1.1b-€292,907,908.00n/a-92.1x25.4x
Wed, 11 Oct 2023€27.9b€879.7m-€451,294,196.00n/a-61.7x31.7x
Fri, 08 Sep 2023€28.2b€869.4m-€452,165,717.00n/a-62.3x32.4x
Sun, 06 Aug 2023€26.3b€837.5m-€450,321,106.00n/a-58.5x31.4x
Tue, 04 Jul 2023€19.6b€664.2m-€558,059,612.00n/a-35.1x29.5x
Thu, 01 Jun 2023€20.5b€679.9m-€570,855,261.00n/a-35.8x30.1x
Sat, 29 Apr 2023€19.5b€452.1m-€723,668,665.00n/a-27x43.2x
Mon, 27 Mar 2023€18.7b€463.3m-€741,379,158.00n/a-25.3x40.5x
Wed, 22 Feb 2023€19.4b€315.2m-€915,310,143.00n/a-21.2x61.7x
Fri, 20 Jan 2023€19.8b€311.4m-€899,118,532.00n/a-22x63.6x
Sun, 18 Dec 2022€20.5b€317.0m-€915,914,523.00n/a-22.4x64.8x
Tue, 15 Nov 2022€19.9b€324.6m-€938,655,163.00n/a-21.2x61.4x
Thu, 13 Oct 2022€19.8b€195.1m-€995,890,190.00n/a-19.9x101.7x
Sat, 10 Sep 2022€21.8b€170.1m-€963,124,300.00n/a-22.7x128.3x
Mon, 08 Aug 2022€20.0b€167.0m-€949,718,762.00n/a-21.1x119.8x
Wed, 06 Jul 2022€20.3b€394.8m-€636,528,019.00n/a-31.9x51.4x
Fri, 03 Jun 2022€16.0b€379.7m-€613,111,579.00n/a-26x42.1x
Sun, 01 May 2022€15.1b€522.4m-€441,434,657.00n/a-34.3x29x
Tue, 29 Mar 2022€14.2b€501.6m-€424,949,690.00n/a-33.5x28.4x
Thu, 24 Feb 2022€12.9b€468.0m-€401,617,309.00n/a-32.2x27.6x
Sat, 22 Jan 2022€13.1b€467.9m-€401,577,223.00n/a-32.6x28x
Mon, 20 Dec 2021€14.6b€470.7m-€403,661,643.00n/a-36x30.9x
Wed, 17 Nov 2021€14.1b€464.6m-€397,095,870.00n/a-35.6x30.4x
Fri, 15 Oct 2021€13.6b€464.8m-€361,764,522.00n/a-37.7x29.4x
Sun, 12 Sep 2021€14.6b€454.2m-€354,561,673.48n/a-41.2x32.2x
Tue, 10 Aug 2021€13.9b€453.0m-€354,165,121.68n/a-39.3x30.8x
Mon, 03 May 2021€12.7b€191.9m-€558,580,208.62n/a-22.7x65.9x
Price to Earnings Ratio

-22.7x


Total Market Cap: €12.7bTotal Earnings: -€558,580,208.62Total Revenue: €191.9mTotal Market Cap vs Earnings and Revenue0%0%0%
Belgian Biotech Industry Price to Earnings3Y Average -40.6x202220232024
Current Industry PE
  • Investors are pessimistic on the Belgian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 44.1x is higher than the industry's current PS ratio of 16.3x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Revenues for these companies have grown 86% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Belgian Healthcare industry?

BE Market1.33%
Healthcare2.47%
Biotech1.22%
Biotech1.22%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ARGX argenx€346.201.2%
+€249.4m
1.0%PS17.4x
ALIMG DMS Imaging€0.022.1%
+€595.8k
-12.0%PS0.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

BIOS

€0.016

BioSenic

7D

-20.1%

1Y

-81.8%

ARGX

€346.20

argenx

7D

1.2%

1Y

1.0%

ALIMG

€0.02

DMS Imaging

7D

2.1%

1Y

-12.0%

CYAD

€0.32

Celyad Oncology

7D

-3.4%

1Y

-52.4%

MDXH

€3.02

MDxHealth

7D

-5.6%

1Y

-52.3%